Rhythm Biosciences Limited (ASX:RHYOA)

Australia · Delayed Price · Currency is AUD

0.0100

0.00 (0.00%)

At close: Oct 23, 2026

Market Cap	24.42M -9.9%
Revenue (ttm)	1.74M -47.7%
Net Income	-5.93M
EPS	-0.02
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	8,162
Open	0.0100
Previous Close	0.0100
Day's Range	0.0100 - 0.0100
52-Week Range	0.0080 - 0.1300
Beta	n/a
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 10, 2026

About Rhythm Biosciences

Rhythm Biosciences Limited, a medical diagnostics company, develops and commercialises medical diagnostic tests for cancer detection in Australia and the United States. The company offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. Rhythm Biosciences Limited was incorporated in 2017 and is headquartered in Parkville, Australia. [Read more]

Industry Diagnostics & Research

Sector Healthcare

Founded 2017

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol RHYOA

Financial Performance

In fiscal year 2026, Rhythm Biosciences's revenue was 1.74 million, a decrease of -47.67% compared to the previous year's 3.33 million. Losses were -5.93 million, 54.9% more than in 2025.

Financial Statements